Shares outstanding increased 0.6%
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Free-cash-flow margin changed +2788 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1028 basis points from the comparable as-filed period.
Current long-term debt changed +30.0% from the comparable as-filed period.
Debt / revenue changed -7234 basis points from the comparable as-filed period.
Debt / equity changed -1382 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Debt / assets changed -333 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net debt changed -13.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -217 basis points from the comparable as-filed period.
Gross debt changed -3.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Reported total debt changed -3.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed -12.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +5.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Noncurrent long-term debt changed -4.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed +7.4% from the comparable as-filed period.
SBC / revenue changed -39 basis points from the comparable as-filed period.
Research & development changed +2.3% from the comparable as-filed period.
Receivables / revenue changed -21 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -3.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +2.2% from the comparable as-filed period.
Current liabilities changed -3.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +4.2% from the comparable as-filed period.
Shares outstanding changed +0.5% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Operating cash-flow margin changed +766 basis points from the comparable as-filed period.
Free-cash-flow margin changed +2759 basis points from the comparable as-filed period.
Receivables / revenue changed +265 basis points from the comparable as-filed period.
Debt / revenue changed -5849 basis points from the comparable as-filed period.
Noncurrent long-term debt changed -8.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Net debt changed -5.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital changed +4.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cost of revenue changed +12.7% from the comparable as-filed period.
R&D / revenue changed -205 basis points from the comparable as-filed period.
Debt / assets changed -104 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Inventory changed -4.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current long-term debt changed from 0 to 1149000000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Working capital / assets changed +54 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed +2.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed -58 basis points from the comparable as-filed period.
Research & development changed +1.5% from the comparable as-filed period.
Operating cash flow / net income changed -5.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Reported total debt changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross debt changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -1.6% from the comparable as-filed period.
Selling, general & administrative changed +1.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.